Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal disaccharidases and related brush-border digestive enzymes are a specialized group of hydrolases anchored to the microvilli of enterocytes in the small intestine. This group primarily includes sucrase-isomaltase (SI), maltase-glucoamylase (MGAM), lactase (LCT), and trehalase (TREH), which catalyze the final step of carbohydrate digestion by hydrolyzing disaccharides and oligosaccharides into monosaccharides like glucose, fructose, and galactose (StatPearls, 2023; UniProt, 2024). These enzymes are essential for nutrient absorption and systemic energy homeostasis. In the context of type 2 diabetes and obesity, they serve as therapeutic targets for alpha-glucosidase inhibitors, which delay glucose absorption to manage postprandial hyperglycemia (PubMed, 2022). Deficiencies in these enzymes, whether congenital or acquired, lead to malabsorption disorders such as lactose intolerance and congenital sucrase-isomaltase deficiency (CSID), resulting in osmotic diarrhea and flatulence (NIH, 2023). Pharmacological management involves either the inhibition of these enzymes to control metabolic disorders or enzyme replacement therapy to restore digestive function in deficient patients.
Competitive inhibition of alpha-glucosidase enzymes (sucrase, maltase, glucoamylase) to delay carbohydrate digestion and glucose absorption, or exogenous enzyme replacement to restore hydrolytic activity in deficiency states (StatPearls, 2023).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal disaccharidases and related brush-border digestive enzymes.